Combination Therapy: The Way Forward in Multiple Myeloma

被引：0
|
作者：
不详
机构：
来源：
AMERICAN JOURNAL OF MANAGED CARE | 2016年 / 22卷
关键词：
HETEROGENEITY; DEXAMETHASONE;
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：22 / 23
页数：2
相关论文
共 50 条
  • [21] Synergistic combination therapy with cotylenin A and vincristine in multiple myeloma models
    Takahashi, Tsutomu
    Honma, Yoshio
    Miyake, Takaaki
    Adachi, Koji
    Takami, Saki
    Okada, Masahiro
    Kumanomidou, Satoshi
    Ikejiri, Fumiyoshi
    Jo, Yumi
    Onishi, Chie
    Kawakami, Koshi
    Moriyama, Ichiro
    Inoue, Masaya
    Tanaka, Junko
    Suzumiya, Junji
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (04) : 1801 - 1809
  • [22] Early discontinuation of combination therapy in multiple myeloma: A pilot analysis
    Lin, Jay
    Lingohr-Smith, Melissa
    Omar, Mohamed
    Chen, Clara
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [23] Combination therapy for treating drug-resistant multiple myeloma
    Kim, Byung-Gyu
    Choi, Sung Hee
    Luo, George
    Kim, Seong-Jin
    Malek, Ehsan
    Driscoll, James
    Letterio, John
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [24] Current developments in the combination therapy of relapsed/refractory multiple myeloma
    Maples, Kathryn T.
    Joseph, Nisha S.
    Harvey, R. Donald
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (12) : 1021 - 1035
  • [25] Carfilzomib Triple Combination Therapy: A Review in Relapsed Multiple Myeloma
    Hoy, Sheridan M.
    TARGETED ONCOLOGY, 2016, 11 (02) : 255 - 262
  • [26] Quisinostat, bortezomib, and dexamethasone combination therapy for relapsed multiple myeloma
    Moreau, Philippe
    Facon, Thierry
    Touzeau, Cyrille
    Benboubker, Lotfi
    Delain, Martine
    Badamo-Dotzis, Julie
    Phelps, Charles
    Doty, Christopher
    Smit, Hans
    Fourneau, Nele
    Forslund, Ann
    Hellemans, Peter
    Leleu, Xavier
    LEUKEMIA & LYMPHOMA, 2016, 57 (07) : 1546 - 1559
  • [27] The emerging role of carfilzomib combination therapy in the management of multiple myeloma
    Moreau, Philippe
    EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (02) : 265 - 290
  • [28] Combination therapy of Thalidomide and Peginterferon in patients with progressive multiple myeloma
    Kasper, B
    Moehler, T
    Neben, K
    Ho, AD
    Goldschmidt, H
    ANNALS OF ONCOLOGY, 2004, 15 (01) : 176 - 177
  • [29] Multiple myeloma:: Increase of the effectiveness of Velcade® (Bortezomib) through combination therapy
    Aschoff, K
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2005, 32 (05) : 284 - 284
  • [30] LUNG TOXICITY OF MELPHALAN AND STEROID COMBINATION THERAPY IN MULTIPLE-MYELOMA
    GILES, FJ
    SINGER, CRJ
    GOLDSTONE, AH
    TOBIAS, JS
    RICHARDS, JDM
    BRITISH JOURNAL OF CANCER, 1988, 58 (04) : 545 - 545
12345